Close Menu
  • Home
  • International
  • News
  • Lifestyle
  • Law
  • Business
  • Education
  • Vaping

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Client Challenge

June 5, 2026

They Already Ruined Cannabis. Now Psychedelics Are Next.

June 5, 2026

Vertanical Secures FDA Breakthrough Designation for Cannabis Pain Drug

June 5, 2026
Facebook X (Twitter) Instagram
Friday, June 5
  • Home
  • Contact
  • Privacy Policy
  • Terms & Conditions
Facebook X (Twitter) Instagram LinkedIn VKontakte
Smoke Advantage
  • Home
  • International

    Medical Cannabis Patients Report Reduced Prescription Drug Use

    May 8, 2026

    Cannabis Europa Heads to London Amid €1.5 Billion European Market Surge

    May 6, 2026

    Ananda Pharma to Begin Dosing in NHS CBD Endometriosis Trial

    March 7, 2026
  • News

    Vertanical Secures FDA Breakthrough Designation for Cannabis Pain Drug

    June 5, 2026

    Exercise common amongst cannabis users, new study finds

    June 5, 2026

    Amsterdam Drops Coffeeshop Tourist Ban In New Coalition Deal

    June 4, 2026

    Wyoming Official Issues ‘Objection’ To Rescheduling Marijuana Under State Law Following Trump’s Federal Move

    June 4, 2026

    UK Medical Cannabis Patients Report Improved Mental Health Symptoms

    June 3, 2026
  • Lifestyle

    Rappin’ The Rivers Is Building Montana’s Hip-Hop Outpost

    June 4, 2026

    Harry Styles Says He Did A Lot of Mushrooms Making ‘Fine Line.’ A Top Psychedelic Scientist Explains Why It Tracks.

    May 31, 2026

    Twenty-One Years Later, Conor Oberst Is More Wide Awake Than Ever

    May 29, 2026

    What the VA Won’t Prescribe: A Joint

    May 27, 2026

    Scary Movie Went All In On Marketing To Stoners. A Vape, A Bong Popcorn Bucket, The Whole Thing.

    May 25, 2026
  • Law

    Client Challenge

    June 5, 2026

    Kentucky Gov. Signs Order to Add 15 New Qualifying Conditions for Medical Cannabis

    June 4, 2026

    Minnesota Gov. Signs Law Streamlining Medical and Adult-Use Cannabis Supply Chains

    June 2, 2026

    NORML Seeks to Participate in DEA Hearings on Cannabis Rescheduling 

    May 29, 2026

    Massachusetts Regulators to Audit Cannabis THC Potency Levels

    May 26, 2026
  • Business

    They Already Ruined Cannabis. Now Psychedelics Are Next.

    June 5, 2026

    The Cannabis Consumer Has Grown Up. Has Your Hardware?  – Cannabis & Tech Today

    June 4, 2026

    Pre-Rolls Overtake Flower as Consumer Preferences Shift – Cannabis & Tech Today

    May 30, 2026

    Marc Shepard Built NECANN for the Locals

    May 29, 2026

    Federal Labor Decision Inspires More Missouri Marijuana Workers To Seek Unionization

    May 27, 2026
  • Education

    The “Canna-Tourism” Guide to the Twin Cities

    June 4, 2026

    CBD Dosage Guide for Beginners (India) – Buy CBD Oil India | Licensed Under Ministry of Ayush

    June 2, 2026

    Marijuana Components Have ‘Consistent’ Anti-Tumor Effects In Glioblastoma And Other Cancers, Scientific Review Shows

    May 31, 2026

    Beyond Cannabinoids: Unlocking Cannabistilbenes

    May 29, 2026

    How the Endocannabinoid System Controls Sleep, Mood & Pain – Buy CBD Oil India | Licensed Under Ministry of Ayush

    May 27, 2026
  • Vaping

    France’s Criminilization of Nicotine Pouches Raises Questions Over Tobacco Harm Reduction Policy

    June 4, 2026

    Psychedelics, Vapes and Smart Apps: Smoking Cessation Science Evolves Beyond Traditional NRTs

    June 2, 2026

    Review: Coolfire Z Air – Innokin

    May 31, 2026

    Tobacco Harm Reduction: An Especially Beneficial Public Health Tool for Disadvantaged Groups

    May 29, 2026

    Global Vaping Research 2026: Cancer Concerns, Nicotine Science and Smoking Cessation Evidence

    May 27, 2026
Smoke Advantage
You are at:Home»News»Even the DEA Says Teen Weed Use Is Down. WSJ Still Ties Teen Access to Legalization. Why Ignore the Data?
News

Even the DEA Says Teen Weed Use Is Down. WSJ Still Ties Teen Access to Legalization. Why Ignore the Data?

adminBy adminMarch 20, 2026No Comments6 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email

The Wall Street Journal keeps pairing real concerns about teen cannabis with a familiar implication: legalization made the problem worse. But national trend data, recent policy research (and even the DEA’s own youth-facing materials) still don’t show that legal adult markets drove a youth-use surge.

The Wall Street Journal has now run back-to-back pieces nudging readers toward the same conclusion: legal cannabis may be for adults on paper, but in practice it is making marijuana easier for teens to get, easier to hide and harder for schools to control. First came the March 4 school-panic piece about students vaping pot in bathrooms and even during class. Then came the March 14 health piece, which warned that even low-level teen cannabis use is linked to worse mental-health and academic outcomes.

The problem is not that the Journal found fake science. It didn’t. Teen cannabis use can be risky. High-THC products are real. Adolescents should not be using them. But that still does not prove legalization caused a rise in youth use, and it definitely does not justify treating legal adult markets as the obvious villain every time a teen-cannabis story needs one.

That’s the sleight of hand in this coverage. The Journal keeps blending together three separate claims and hoping readers won’t notice the seams.

Also read: Teens Didn’t Just Discover Weed. So Why Is The Wall St. Journal Acting Like They Did?

One claim is that cannabis can be harmful for teens. That is supported by a substantial body of research, and the March 14 article leans on exactly that. Another claim is that today’s commercial products can be far more potent than the flower most people think of when they picture old-school marijuana. Also true. But the third claim—the one doing the political work—is that legalization has made teen cannabis use worse in a broad, population-level sense. That is the part the data do not cleanly support.

Start with the basic trend line. Monitoring the Future, the long-running national survey of U.S. students, continues to show that teen cannabis use is not exploding. The 2025 and 2026 releases show levels that are low by historical standards, and the longer arc is downward from past peaks. The National Institute on Drug Abuse’s summary of Monitoring the Future says adolescent drug use generally remained low in 2025, while the 2026 report shows only small year-to-year movement in cannabis use rather than some legalization-era stampede.

That long-run pattern matters because the media story so often runs in the opposite direction. Readers are handed a string of anecdotes—students passing vape pens, schools buying sensors, administrators describing bathroom cat-and-mouse—and invited to infer that legalization must be fueling a youth crisis. But anecdote is not a trend, and school visibility is not the same thing as overall prevalence. In fact, even the Journal’s March 4 article acknowledged that teen cannabis use overall had declined slightly since 2019, even while school officials said they were seeing more on-campus use. Those two things can coexist without proving legalization caused more kids to use marijuana.

That distinction is where the scare story starts to wobble.

The best recent policy research does not show a youth-use surge driven by recreational marijuana laws. A 2024 study in JAMA Psychiatry examining Youth Risk Behavior Survey data from 1993 to 2021 found no evidence that recreational marijuana laws encouraged youth marijuana use. A separate 2024 study in JAMA Pediatrics looking at legalization and retail sales through 2021 found no net increases in adolescent cannabis, alcohol, cigarette or e-cigarette use associated with recreational legalization or retail sales.

That does not mean every concern is fake. It means the broader causal narrative remains weak.

And yet that weak causal narrative is exactly what the Journal keeps advancing. The March 14 piece says legalization in many states has made it easier for teens to access highly potent and convenient forms of cannabis. The March 4 piece similarly frames legalization as making marijuana culturally acceptable and easy to get. Notice the move: the articles do not have to prove that teen use shot up statewide after legalization if they can instead make legalization feel like the background explanation for every school bathroom vape alarm and every worried quote from an administrator.

But “more potent products exist in legal markets” is not the same claim as “legalization increased teen use.” “Schools are seeing more vaping incidents” is not the same claim as “more teenagers are using cannabis overall.” And “adolescent cannabis can be harmful” is definitely not the same claim as “legalization failed.” Those are separate propositions. The Journal keeps stacking them together as if they add up to one obvious conclusion. They do not.

There is also a simpler explanation for some of what schools are seeing: devices changed, visibility changed and enforcement changed. Vapes are easier to conceal than joints. Edibles are easier to mistake for ordinary snacks. Sensors and cameras make it easier to catch activity that once would have gone unnoticed. On-campus detection can rise even while overall use is flat or falling. That is not a pro-cannabis talking point. It is just the difference between surveillance and prevalence.

Even the DEA’s own youth-facing materials now concede the bigger point prohibitionists keep trying to dodge: youth marijuana use has declined over the long term. The agency’s “Just Think Twice” messaging acknowledges that past-year cannabis use among 8th, 10th and 12th graders fell from 1995 to 2025. That does not settle every debate about legalization, potency or youth risk. But it should at least retire the lazy storyline that legal weed unleashed some new teen-use boom.

What the Journal is doing instead is more subtle and more familiar. It is taking real science about teen risk and using it to support a broader panic narrative about legalization. That panic is emotionally intuitive. It is also much less supported by the actual trend data than these stories would have readers believe.

Protecting kids is a serious issue. So is getting the story right. If the concern is youth access, then talk honestly about diversion, parental storage, packaging, enforcement and school policy. If the concern is potency, then argue about potency. If the concern is adolescent brain health, make that case directly. But don’t keep laundering a weak legalization narrative through every alarming teen-cannabis anecdote you can find.

The science on teen risk is real. The Journal’s legalization-is-to-blame implication is the part that keeps failing inspection.

Photo: Shutterstock

Source link

access Data DEA Ignore Legalization Teen Ties Weed WSJ
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Previous ArticleFederal CBD Health Insurance Plan Will Reportedly Allow THC Amount Far Exceeding Hemp Limit Signed By Trump
Next Article Why is the E-liquid with nicotine called salts?
admin

Related Posts

Vertanical Secures FDA Breakthrough Designation for Cannabis Pain Drug

June 5, 2026

Exercise common amongst cannabis users, new study finds

June 5, 2026

Amsterdam Drops Coffeeshop Tourist Ban In New Coalition Deal

June 4, 2026

Comments are closed.

Our Picks

Client Challenge

June 5, 2026

They Already Ruined Cannabis. Now Psychedelics Are Next.

June 5, 2026

Vertanical Secures FDA Breakthrough Designation for Cannabis Pain Drug

June 5, 2026

Exercise common amongst cannabis users, new study finds

June 5, 2026
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • YouTube
  • Vimeo
Don't Miss
Law

Client Challenge

By adminJune 5, 20260

Client Challenge JavaScript is disabled in your browser. Please enable JavaScript to proceed. A required…

They Already Ruined Cannabis. Now Psychedelics Are Next.

June 5, 2026

Vertanical Secures FDA Breakthrough Designation for Cannabis Pain Drug

June 5, 2026

Exercise common amongst cannabis users, new study finds

June 5, 2026

Subscribe to Updates

Get the latest creative news from Smoke Unlimited about Weed & CBD vaping.

From Our Partners
About Us
About Us

Get all the current news stories, latest trends and legislation regarding cannabidiol, products, usages and its benefits. So don’t miss out any buzz and stay tuned! We offer a minute to minute updates regarding Marijuana industry.

Facebook X (Twitter) Instagram Pinterest
Our Picks

Client Challenge

June 5, 2026

They Already Ruined Cannabis. Now Psychedelics Are Next.

June 5, 2026

Vertanical Secures FDA Breakthrough Designation for Cannabis Pain Drug

June 5, 2026
Sponsors
Copyright © 2026. SmokeAdvantage.com
  • Home
  • Contact
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.